Trials / Completed
CompletedNCT02508922
Trial of Vitamin D3 Supplementation in Paediatric Autism
Vitamin D3 for Autism Spectrum Disorder: a Randomized, Double-blind, Placebo-controlled Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- University of Dublin, Trinity College · Academic / Other
- Sex
- All
- Age
- 3 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
To build on a recent case study and open label trial, the investigators want to find out if vitamin D supplementation can influence behavioural and core symptoms of autism.
Detailed description
The investigators will assess behavioural and core symptoms of autism before and after 20 weeks of vitamin D supplementation in a double-blind, placebo-controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vitamin D3 | 2,000iu vitamin D drops will be taken daily for 20 weeks |
| DIETARY_SUPPLEMENT | Placebo | Matching placebo drops will be taken daily for 20 weeks |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-06-01
- Completion
- 2016-07-01
- First posted
- 2015-07-27
- Last updated
- 2016-10-25
Locations
3 sites across 1 country: Ireland
Source: ClinicalTrials.gov record NCT02508922. Inclusion in this directory is not an endorsement.